Second primary malignancy in myelofibrosis patients treated with ruxolitinib

N. Polverelli, E.M. Elli, E. Abruzzese, G.A. Palumbo, G. Benevolo, M. Tiribelli, M. Bonifacio, A. Tieghi, G. Caocci, M. D'Adda, M. Bergamaschi, G. Binotto, F.H. Heidel, F. Cavazzini, M. Crugnola, N. Pugliese, C. Bosi, A. Isidori, D. Bartoletti, G. AuteriR. Latagliata, L. Gandolfi, B. Martino, L. Scaffidi, D. Cattaneo, F. D’Amore, M.M. Trawinska, R. Stella, U. Markovic, L. Catani, F. Pane, A. Cuneo, M. Krampera, G. Semenzato, R.M. Lemoli, N. Vianelli, M. Breccia, D. Russo, M. Cavo, A. Iurlo, F. Palandri

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Second primary malignancy in myelofibrosis patients treated with ruxolitinib'. Together they form a unique fingerprint.

Medicine & Life Sciences